Genomic Vision announced that it has signed an exclusive distribution agreement with AmCare Genomics Laboratory to market the FSHD diagnostic assay in China. “We are thrilled to have acquired Genomic Vision’s technology and signed an exclusive distribution agreement for the FSHD diagnostic assay in China. Thanks to our large network and connections within the neurology and FSHD communities in China, …
Recent Comments